BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19318700)

  • 1. Cancer morbidity in British military veterans included in chemical warfare agent experiments at Porton Down: cohort study.
    Carpenter LM; Linsell L; Brooks C; Keegan TJ; Langdon T; Doyle P; Maconochie NE; Fletcher T; Nieuwenhuijsen MJ; Beral V; Venables KM
    BMJ; 2009 Mar; 338():b655. PubMed ID: 19318700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in British military participants in human experimental research into chemical warfare agents at Porton Down: cohort study.
    Venables KM; Brooks C; Linsell L; Keegan TJ; Langdon T; Fletcher T; Nieuwenhuijsen MJ; Maconochie NE; Doyle P; Beral V; Carpenter LM
    BMJ; 2009 Mar; 338():b613. PubMed ID: 19318699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and cancer in Porton Down subjects.
    Sim MR
    BMJ; 2009 Mar; 338():b358. PubMed ID: 19318698
    [No Abstract]   [Full Text] [Related]  

  • 4. Mortality and cancer incidence in UK military veterans involved in human experiments at Porton Down: 48-year follow-up.
    Archer G; Keegan TJ; Carpenter LM; Venables KM; Fear NT
    Int J Epidemiol; 2023 Aug; 52(4):1025-1034. PubMed ID: 37164653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstructing exposures from the UK chemical warfare agent human research programme.
    Keegan T; Nieuwenhuijsen M; Fletcher T; Brooks C; Doyle P; Maconochie N; Carpenter L; Venables K
    Ann Occup Hyg; 2007 Jul; 51(5):441-50. PubMed ID: 17602209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposures recorded for participants in the UK Chemical Warfare Agent Human Research Programme, 1941-1989.
    Keegan TJ; Walker SA; Brooks C; Langdon T; Linsell L; Maconochie NE; Doyle P; Fletcher T; Nieuwenhuijsen MJ; Carpenter LM; Venables KM
    Ann Occup Hyg; 2009 Jan; 53(1):83-97. PubMed ID: 19131404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms, ill-health and quality of life in a support group of Porton Down veterans.
    Allender S; Maconochie N; Keegan T; Brooks C; Fletcher T; Nieuwenhuijsen MJ; Doyle P; Carpenter LM; Venables KM
    Occup Med (Lond); 2006 Aug; 56(5):329-37. PubMed ID: 16847038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical findings in 111 ex-Porton Down volunteers.
    Lee HA; Gabriel R; Bale AJ; Welch D
    J R Army Med Corps; 2004 Mar; 150(1):14-9. PubMed ID: 15149006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarin Exposures in A Cohort of British Military Participants in Human Experimental Research at Porton Down 1945-1987.
    Keegan TJ; Carpenter LM; Brooks C; Langdon T; Venables KM
    Ann Work Expo Health; 2017 Dec; 62(1):17-27. PubMed ID: 29136135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating a
    Schmidt U
    J R Army Med Corps; 2019 Aug; 165(4):284-290. PubMed ID: 31164389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porton defends nerve-gas tests on humans.
    Mason I
    New Sci; 1987 Jul; 115(1569):30. PubMed ID: 11655830
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality and morbidity of members of the British Nuclear Tests Veterans Association and the New Zealand Nuclear Tests Veterans Association and their families.
    Roff SR
    Med Confl Surviv; 1999; 15 Suppl 1():i-ix, 1-51. PubMed ID: 10467894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Military chemical warfare agent human subjects testing: part 1--history of six-decades of military experiments with chemical warfare agents.
    Brown M
    Mil Med; 2009 Oct; 174(10):1041-8. PubMed ID: 19891215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of cancer among UK Gulf war veterans: cohort study.
    Macfarlane GJ; Biggs AM; Maconochie N; Hotopf M; Doyle P; Lunt M
    BMJ; 2003 Dec; 327(7428):1373. PubMed ID: 14670879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality follow-up of veterans who participated in military chemical and biological warfare agent testing between 1962 and 1972.
    Kang HK; Bullman T
    J Toxicol Environ Health A; 2009; 72(23):1550-2. PubMed ID: 20077228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some recollections of Porton in World War 1. Commentary.
    Garner JP
    J R Army Med Corps; 2003 Jun; 149(2):138-41. PubMed ID: 12929523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort Profile: The Porton Down Veterans cohort study.
    Archer G; Keegan TJ; Venables KM; Carpenter LM; Fear NT
    Int J Epidemiol; 2022 Aug; 51(4):e200-e205. PubMed ID: 35104850
    [No Abstract]   [Full Text] [Related]  

  • 18. Military chemical warfare agent human subjects testing: part 2--long-term health effects among participants of U.S. military chemical warfare agent testing.
    Brown M
    Mil Med; 2009 Oct; 174(10):1049-54. PubMed ID: 19891216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fifty year mortality follow-up study of veterans exposed to low level chemical warfare agent, mustard gGas.
    Bullman T; Kang H
    Ann Epidemiol; 2000 Jul; 10(5):333-8. PubMed ID: 10942882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethics at Porton Down.
    Sharp D
    Lancet; 2006 Aug; 368(9536):631-2. PubMed ID: 16920454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.